Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$14.22 - $18.38 $172,573 - $223,059
-12,136 Closed
0 $0
Q1 2020

Apr 28, 2020

SELL
$12.22 - $17.99 $180,049 - $265,064
-14,734 Reduced 54.83%
12,136 $212,000
Q4 2019

Jan 27, 2020

BUY
$14.63 - $17.84 $147,002 - $179,256
10,048 Added 59.73%
26,870 $468,000
Q3 2019

Nov 04, 2019

BUY
$15.09 - $17.09 $253,843 - $287,487
16,822 New
16,822 $255,000
Q3 2018

Nov 02, 2018

SELL
$18.89 - $20.49 $635,195 - $688,996
-33,626 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$18.13 - $19.4 $344,288 - $368,406
18,990 Added 129.75%
33,626 $632,000
Q1 2018

May 08, 2018

SELL
$18.92 - $21.52 $60,279 - $68,562
-3,186 Reduced 17.88%
14,636 $0
Q4 2017

Feb 12, 2018

BUY
$18.31 - $22.24 $326,320 - $396,361
17,822
17,822 $350,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Doliver Advisors, LP Portfolio

Follow Doliver Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.